.png)
Extremity Reconstruction Devices Market by Type and Biomaterial - Global Industry Analysis and Forecast to 2027
Published On : August 2017 Pages : 105 Category: Medical Devices Report Code : HC08193
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Trend Analysis
The global extremity reconstruction devices market is expected to be around $4 billion by 2027. The major driving factors for this market are increasing incidence of sports and trauma injuries, technological advancements related to extremity implants, increasing awareness among people for leading an active lifestyle and increasing risk of degenerative joint disorders resulting from rising incidence of diabetes and obesity. In the U.S. alone, each year about 30 million children and teenagers take part in some form of organized sport where more than 3.5 million sports injuries are reported. Almost one-third of the injuries reported in children are sports related injuries. Around 21% of traumatic injuries related to the brain are attributed to sports and recreational activities. With increasing cases of sports injuries, the demand for minimally invasive techniques for joint repair and reconstruction has significantly increased in recent years. Moreover, rising geriatric population is also expected to largely contribute to the growth of extremity reconstruction devices market over the forecast period as elder people are more susceptible to joint related disorders such as Arthritis. However, factors such as high cost of extremity reconstruction procedures and stringent regulatory approval policies can hamper the market growth during the forecast period.
Product Outlook and Trend Analysis
Upper extremity reconstruction segment dominated the global extremity reconstruction market in 2017 due to rising incidence of joint disorders related to upper extremities such as fractures and arthritis. Within the upper extremity replacement segment, shoulder reconstruction sub-segment held a major market share in 2017 owing to significant increase in the number of patients opting for shoulder replacement surgeries, positive outcomes of those replacement procedures and technological advancements resulting in development on improved shoulder implants. The ankle reconstruction devices segment is expected to exhibit lucrative growth during the forecast period due to increasing incidence of ankle arthritis, emergence of minimally invasive procedures for ankle reconstruction and increasing adoption of these devices in developed countries.
Biomaterial Outlook and Trend Analysis
Metallic biomaterials segment held the largest share of the global extremity reconstruction devices market in 2017. This significant market share can be attributed to the excellent mechanical stiffness provided by these implants which provides sufficient stability to unstable fracture sites which assists in effective biological repair.
Regional Outlook and Trend Analysis
North America dominated the global extremity reconstruction devices market in 2017 due to high prevalence of joint related disorders, increase in aging population, availability of robust healthcare infrastructure along with awareness related to benefits of extremity reconstruction procedures supplemented by high disposable income. However, Asia-Pacific extremity reconstruction devices market is expected to grow at a significant pace during the forecast period owing to the presence of extensively unmet medical needs and increasing healthcare expenditure in emerging countries such China and India.
Competitive Analysis
The key players operating in the global extremity reconstruction devices market focus on designing and developing advanced extremity fixation technologies to introduce improved minimally invasive solution for extremity reconstruction. For instance, in January 2022, Orthofix International N.V. introduced JuniOrtho, an advanced product for extremity fixation in pediatrics. Such product developments help them to strengthen their extremity reconstruction portfolio and sustain their leading position in the market. Some of the major players in the global extremity reconstruction market are, DePuy Orthopaedics, Inc.(a subsidiary of Johnson & Johnson Services, Inc.), Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew PLC, Integra LifeSciences Holdings Corporation, Wright Medical Group N.V., Acumed LLC, Arthrex, Inc., CONMED Corporation, Skeletal Dynamics LLC, Advanced Orthopeadic Solutions, Bioretec Ltd. and Cardinal Health, Inc.
Market Opportunities
The key opportunities for global extremity reconstruction devices market lies in development of advanced reconstruction and replacement solutions which are minimally invasive leading to shorter recovery times and better functioning of extremities. Emerging markets will also generate favorable demand for extremity reconstruction devices in coming years as awareness related to benefits of joint reconstruction and replacement is on the rise in developing countries such as India and China.
Extremity Reconstruction Devices Market Segmentation:
By Product:
- Upper Extremity Reconstruction
- Elbow Reconstruction
- Shoulder Reconstruction
- Total Standard Replacement
- Partial Shoulder Replacement
- Total Reverse Replacement
- Stemless Total Shoulder Replacement
- Hand & Wrist Reconstruction
- Lower Extremity Reconstruction
- Ankle Reconstruction Devices
- Ankle Fusion
- Ankle Replacement
- Foot Devices
- Hind foot Fusion
- Other Fusions
By Biomaterial:
- Metallic Biomaterial
- Polymeric Biomaterial
- Natural Biomaterial
- Ceramic Biomaterial
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Extremity Reconstruction Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
- Upper Extremity Reconstruction
- Elbow Reconstruction
- Shoulder Reconstruction
- Total Standard Replacement
- Partial Shoulder Replacement
- Total Reverse Replacement
- Stemless Total Shoulder Replacement
- Hand & Wrist Reconstruction
- Lower Extremity Reconstruction
- Ankle Reconstruction Devices
- Ankle Fusion
- Ankle Replacement
- Foot Devices
- Hind foot Fusion
- Other Fusions
- Extremity Reconstruction Devices Market, By Biomaterial, Estimates and Forecast, 2017-2027 ($Million)
- Metallic Biomaterial
- Polymeric Biomaterial
- Natural Biomaterial
- Ceramic Biomaterial
- Extremity Reconstruction Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Extremity Reconstruction Devices Market, By Country
- North America Extremity Reconstruction Devices Market, By Product
- North America Extremity Reconstruction Devices Market, By Biomaterial
- U.S. Extremity Reconstruction Devices Market, By Product
- U.S. Extremity Reconstruction Devices Market, By Biomaterial
- Canada Extremity Reconstruction Devices Market, By Product
- Canada Extremity Reconstruction Devices Market, By Biomaterial
- Mexico Extremity Reconstruction Devices Market, By Product
- Mexico Extremity Reconstruction Devices Market, By Biomaterial
-
- Europe
- Europe Extremity Reconstruction Devices Market, By Country
- Europe Extremity Reconstruction Devices Market, By Product
- Europe Extremity Reconstruction Devices Market, By Biomaterial
- Germany Extremity Reconstruction Devices Market, By Product
- Germany Extremity Reconstruction Devices Market, By Biomaterial
- France Extremity Reconstruction Devices Market, By Product
- France Extremity Reconstruction Devices Market, By Biomaterial
- UK Extremity Reconstruction Devices Market, By Product
- UK Extremity Reconstruction Devices Market, By Biomaterial
- Italy Extremity Reconstruction Devices Market, By Product
- Italy Extremity Reconstruction Devices Market, By Biomaterial
- Spain Extremity Reconstruction Devices Market, By Product
- Spain Extremity Reconstruction Devices Market, By Biomaterial
- Rest of Europe Extremity Reconstruction Devices Market, By Product
- Rest of Europe Extremity Reconstruction Devices Market, By Biomaterial
-
- Asia-Pacific
- Asia-Pacific Extremity Reconstruction Devices Market, By Country
- Asia-Pacific Extremity Reconstruction Devices Market, By Product
- Asia-Pacific Extremity Reconstruction Devices Market, By Biomaterial
- Japan Extremity Reconstruction Devices Market, By Product
- Japan Extremity Reconstruction Devices Market, By Biomaterial
- Australia Extremity Reconstruction Devices Market, By Product
- Australia Extremity Reconstruction Devices Market, By Biomaterial
- India Extremity Reconstruction Devices Market, By Product
- India Extremity Reconstruction Devices Market, By Biomaterial
- South Korea Extremity Reconstruction Devices Market, By Product
- South Korea Extremity Reconstruction Devices Market, By Biomaterial
- Rest of Asia-Pacific Extremity Reconstruction Devices Market, By Product
- Rest of Asia-Pacific Extremity Reconstruction Devices Market, By Biomaterial
- Asia-Pacific
-
- Rest of the World
- Rest of the World Extremity Reconstruction Devices Market, By Country
- Rest of the World Extremity Reconstruction Devices Market, By Product
- Rest of the World Extremity Reconstruction Devices Market, By Biomaterial
- Brazil Extremity Reconstruction Devices Market, By Product
- Brazil Extremity Reconstruction Devices Market, By Biomaterial
- South Africa Extremity Reconstruction Devices Market, By Product
- South Africa Extremity Reconstruction Devices Market, By Biomaterial
- Saudi Arabia Extremity Reconstruction Devices Market, By Product
- Saudi Arabia Extremity Reconstruction Devices Market, By Biomaterial
- Turkey Extremity Reconstruction Devices Market, By Product
- Turkey Extremity Reconstruction Devices Market, By Biomaterial
- United Arab Emirates Extremity Reconstruction Devices Market, By Product
- United Arab Emirates Extremity Reconstruction Devices Market, By Biomaterial
- Others Extremity Reconstruction Devices Market, By Product
- Others Extremity Reconstruction Devices Market, By Biomaterial
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increasing Incidence of Joint Related Disorders
3.3.1.2. Rising Geriatric Population Around the World
3.3.1.3. Increasing Patient Preference Towards Leading an Active Lifestyle
3.3.1.4. Increasing Incidence of Obesity and Diabetes
3.3.2. Restraints
3.3.2.1. High Cost of Extremity Reconstruction Procedures
3.3.2.2. Stringent Regulatory Approval Policies
3.3.3. Opportunities
3.3.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Extremity Reconstruction Devices Market, By Product
4.1. Introduction
4.2. Extremity Reconstruction Devices Market Assessment and Forecast, By Product, 2017-2027
4.3. Upper Extremity Reconstruction
4.3.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.2.1. Elbow Reconstruction
4.3.2.1.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.2.2. Shoulder Reconstruction
4.3.2.3. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.3.2.4. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.2.4.1. Total Standard Replacement
4.3.2.4.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.2.4.3. Partial Shoulder Replacement
4.3.2.4.4. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.2.4.5. Total Reverse Replacement
4.3.2.4.6. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.2.4.7. Stemless Total Shoulder Replacement
4.3.2.4.8. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.2.5. Hand & Wrist Reconstruction
4.3.2.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Lower Extremity Reconstruction
4.4.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.4.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.2.1. Ankle Reconstruction Devices
4.4.2.1.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.4.2.1.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.2.1.3. Ankle Fusion
4.4.2.1.4. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.2.1.5. Ankle Replacement
4.4.2.1.6. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.2.2. Foot Devices
4.4.2.2.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.4.2.2.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.2.2.3. Hind foot Fusion
4.4.2.2.4. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.2.2.5. Other Fusions
5. Extremity Reconstruction Devices Market, By Biomaterial
5.1. Introduction
5.2. The Extremity Reconstruction Devices Market Assessment and Forecast, By Biomaterial, 2017-2027
5.3. Metallic Biomaterial
5.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.4. Polymeric Biomaterial
5.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.5. Natural Biomaterial
5.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.6. Ceramic Biomaterial
5.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6. Extremity Reconstruction Devices Market, By Region
6.1. Introduction
6.2. Extremity Reconstruction Devices Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.3. North America
6.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.3.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.3.3.1. U.S.
6.3.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3.1.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.3.3.2. Canada
6.3.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3.2.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.3.3.3. Mexico
6.3.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.3.3.3.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.4. Europe
6.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.4.3.1. Germany
6.4.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.1.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.4.3.2. France
6.4.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.2.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.3. UK
6.4.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.3.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.4.3.4. Italy
6.4.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.4.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.4.3.5. Spain
6.4.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.5.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.4.3.6. Russia
6.4.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.6.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.4.3.7. Rest of Europe
6.4.3.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.4.3.7.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5. Asia-Pacific
6.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5.3.1. Japan
6.5.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.1.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5.3.2. China
6.5.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.2.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5.3.3. Australia
6.5.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.3.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5.3.4. India
6.5.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.4.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5.3.5. South Korea
6.5.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.5.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5.3.6. Taiwan
6.5.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.6.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.5.3.7. Rest of Asia-Pacific
6.5.3.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.5.3.7.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.6. Rest of the World
6.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.6.3.1. Brazil
6.6.3.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.1.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.6.3.2. Turkey
6.6.3.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.2.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.6.3.3. Saudi Arabia
6.6.3.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.3.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.6.3.4. South Africa
6.6.3.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.4.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.6.3.5. United Arab Emirates
6.6.3.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.5.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
6.6.3.6. Others
6.6.3.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6.6.3.6.2. Market Assessment and Forecast, By Biomaterial, 2017-2027 ($Million)
7. Company Profiles
7.1. DePuy Orthopaedics, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Key Financials
7.1.4. Strategic Developments
7.2. Zimmer Biomet Holdings, Inc.
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Key Financials
7.2.4. Strategic Developments
7.3. Smith & Nephew PLC
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Key Financials
7.3.4. Strategic Developments
7.4. Integra LifeSciences Holdings Corporation
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Key Financials
7.4.4. Strategic Developments
7.5. Wright Medical Group N.V.
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Key Financials
7.5.4. Strategic Developments
7.6. Acumed LLC
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.7. Arthrex, Inc.
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.8. CONMED Corporation
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Key Financials
7.8.4. Strategic Developments
7.9. Skeletal Dynamics LLC
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Strategic Developments
7.10. Advanced Orthopeadic Solutions
7.10.1. Business Overview
7.10.2. Product Portfolio
7.10.3. Strategic Developments
7.11. Bioretec Ltd.
7.11.1. Business Overview
7.11.2. Product Portfolio
7.11.3. Strategic Developments
7.12. Cardinal Health, Inc.
7.12.1. Business Overview
7.12.2. Product Portfolio
7.12.3. Key Financials
7.12.4. Strategic Developments
List of Tables
Table 1.Extremity Reconstruction Devices Market, By Product ($Million), 2017-2025
Table 2.Upper Extremity Reconstruction Market, By Type ($Million), 2017-2025
Table 3.Upper Extremity Reconstruction Market, By Region ($Million), 2017-2025
Table 4.Elbow Reconstruction Market, By Region ($Million), 2017-2025
Table 5.Shoulder Reconstruction Market, By Type ($Million), 2017-2025
Table 6.Shoulder Reconstruction Market, By Region ($Million), 2017-2025
Table 7.Total Standard Replacement Market, By Region ($Million), 2017-2025
Table 8.Partial Shoulder Replacement Market, By Region ($Million), 2017-2025
Table 9.Total Reverse Replacement Market, By Region ($Million), 2017-2025
Table 10.Stemless Total Shoulder Replacement Market, By Region ($Million), 2017-2025
Table 11.Hand & Wrist Reconstruction Market, By Region ($Million), 2017-2025
Table 12.Lower Extremity Reconstruction Market, By Type ($Million), 2017-2025
Table 13.Lower Extremity Reconstruction Market, By Region ($Million), 2017-2025
Table 14.Ankle Reconstruction Devices Market, By Type ($Million), 2017-2025
Table 15.Ankle Reconstruction Devices Market, By Region ($Million), 2017-2025
Table 16.Ankle Fusion Market, By Region ($Million), 2017-2025
Table 17.Ankle Replacement Market, By Region ($Million), 2017-2025
Table 18.Foot Devices Market, By Type ($Million), 2017-2025
Table 19.Foot Devices Market, By Region ($Million), 2017-2025
Table 20.Hind foot Fusion Market, By Region ($Million), 2017-2025
Table 21.Other Fusions Market, By Region ($Million), 2017-2025
Table 22.Extremity Reconstruction Devices Market, By Biomaterial ($Million), 2017-2025
Table 23.Metallic Biomaterial Market, By Region ($Million), 2017-2025
Table 24.Polymeric Biomaterial Market, By Region ($Million), 2017-2025
Table 25.Natural Biomaterial Market, By Region ($Million), 2017-2025
Table 26.Ceramic Biomaterial Market, By Region ($Million), 2017-2025
Table 27.Extremity Reconstruction Devices Market, By Region ($Million), 2017-2025
Table 28.North America Extremity Reconstruction Devices Market, By Country, 2017-2025 ($Million)
Table 29.North America Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 30.North America Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 31.U.S. Extremity Reconstruction Devices Market, by Product, 2017-2025 ($Million)
Table 32.U.S. Extremity Reconstruction Devices Market, by Biomaterial, 2017-2025 ($Million)
Table 33.Canada Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 34.Canada Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 35.Mexico Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 36.Mexico Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 37.Europe Extremity Reconstruction Devices Market, By Country, 2017-2025 ($Million)
Table 38.Europe Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 39.Europe Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 40.Germany Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 41.Germany Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 42.France Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 43.France Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 44.UK Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 45.UK Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 46.Italy Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 47.Italy Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 48.Spain Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 49.Spain Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 50.Russia Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 51.Russia Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 52.Rest of Europe Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 53.Rest of Europe Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 54.Asia-Pacific Extremity Reconstruction Devices Market, By Country, 2017-2025 ($Million)
Table 55.Asia-Pacific Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 56.Asia-Pacific Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 57.Japan Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 58.Japan Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 59.China Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 60.China Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 61.Australia Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 62.Australia Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 63.India Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 64.India Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 65.South Korea Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 66.South Korea Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 67.Taiwan Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 68.Taiwan Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 69.Rest of Asia-Pacific Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 70.Rest of Asia-Pacific Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 71.Rest of the World Extremity Reconstruction Devices Market, By Country, 2017-2025 ($Million)
Table 72.Rest of the World Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 73.Rest of the World Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 74.Brazil Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 75.Brazil Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 76.Turkey Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 77.Turkey Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 78.Saudi Arabia Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 79.Saudi Arabia Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 80.South Africa Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 81.South Africa Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 82.United Arab Emirates Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 83.United Arab Emirates Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 84.Others Extremity Reconstruction Devices Market, By Product, 2017-2025 ($Million)
Table 85.Others Extremity Reconstruction Devices Market, By Biomaterial, 2017-2025 ($Million)
Table 86.DePuy Orthopaedics, Inc.: Key Strategic Developments, 2017-2017
Table 87.Zimmer Biomet Holdings, Inc.: Key Strategic Developments, 2017-2017
Table 88.Stryker Corporation: Key Strategic Developments, 2017-2017
Table 89.Smith & Nephew PLC: Key Strategic Developments, 2017-2017
Table 90.Integra LifeSciences Holdings Corporation: Key Strategic Developments, 2017-2017
Table 91.Wright Medical Group N.V.: Key Strategic Developments, 2017-2017
Table 92.Acumed LLC: Key Strategic Developments, 2017-2017
Table 93.Arthrex, Inc.: Key Strategic Developments, 2017-2017
Table 94.CONMED Corporation: Key Strategic Developments, 2017-2017
Table 95.Skeletal Dynamics LLC: Key Strategic Developments, 2017-2017
Table 96.Advanced Orthopeadic Solutions: Key Strategic Developments, 2017-2017
Table 97.Bioretec Ltd.: Key Strategic Developments, 2017-2017
Table 98.Cardinal Health, Inc.: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Extremity Reconstruction Devices Market Share, By Product, 2017 & 2025
Figure 2.Extremity Reconstruction Devices Market, By Biomaterial, 2017, ($Million)
Figure 3.Extremity Reconstruction Devices Market, By Region, 2017, ($Million)
Figure 4.Johnson & Johnson Services, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 5.Johnson & Johnson Services, Inc.: Net Revenue Share, By Segment, 2017
Figure 6.Johnson & Johnson Services, Inc.: Net Revenue Share, By Geography, 2017
Figure 7.Zimmer Biomet Holdings, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 8.Zimmer Biomet Holdings, Inc.: Net Revenue Share, By Segment, 2017
Figure 9.Zimmer Biomet Holdings, Inc.: Net Revenue Share, By Geography, 2017
Figure 10.Stryker Corporation: Net Revenues, 2017-2017 ($Million)
Figure 11.Stryker Corporation: Net Revenue Share, By Segment, 2017
Figure 12.Stryker Corporation: Net Revenue Share, By Geography, 2017
Figure 13.Smith & Nephew PLC: Net Revenues, 2017-2017 ($Million)
Figure 14.Smith & Nephew PLC: Net Revenue Share, By Segment, 2017
Figure 15.Smith & Nephew PLC: Net Revenue Share, By Geography, 2017
Figure 16.Integra LifeSciences Holdings Corporation: Net Revenues, 2017-2017 ($Million)
Figure 17.Integra LifeSciences Holdings Corporation: Net Revenue Share, By Segment, 2017
Figure 18.Integra LifeSciences Holdings Corporation: Net Revenue Share, By Geography, 2017
Figure 16.Wright Medical Group N.V.: Net Revenues, 2017-2017 ($Million)
Figure 17.Wright Medical Group N.V.: Net Revenue Share, By Segment, 2017
Figure 18.Wright Medical Group N.V.: Net Revenue Share, By Geography, 2017
Figure 16.CONMED Corporation: Net Revenues, 2017-2017 ($Million)
Figure 17.CONMED Corporation: Net Revenue Share, By Segment, 2017
Figure 18.CONMED Corporation: Net Revenue Share, By Geography, 2017
Figure 16.Cardinal Health, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 17.Cardinal Health, Inc.: Net Revenue Share, By Segment, 2017
Figure 18.Cardinal Health, Inc.: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|